Angelique Danielle Becherini

Recommended Articles

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• What to Do When a Person Is Having an Episode of Seizure: Basic First Aid

  Epilepsy is a range of conditions that affect the brain’s electrical activity. Although there are many types of epilepsy, most of them are characterized by seizures that are unpredictable. People with epilepsy will experience different symptoms depending on the type of seizure they have....

• Last Minute Gift Ideas for People with Fibromyalgia

  It's that time of the year again to buy that special someone a gift. But, with Christmas around the corner, people are still scrambling to find the perfect gift for their loved one. Here are some ideas!This is known as the shopping season in most counties of the world, and starting from Black...

• What Is an Arrhythmia?

  An arrhythmia is the violations of the frequency, rhythm, and sequence of heart contractions.Why do arrythmias occur?...

• How Does a Patient's Surgeon Influence Breast Cancer Treatment Decisions?

  When a patient is diagnosed with breast cancer one of the first treatment options is to remove the affected tissue, typically through a mastectomy. In addition to a mastectomy, a patient may also undergo chemotherapy in order to eradicate traces of the disease that may remain or have spread beyond...

• New Cancer Therapy Shows Promise to Treat a Rare Type of Lymphoma

  A new treatment for cancer, called checkpoint inhibitors, are showing promise with several types of cancer, including a rare type of lymphoma, called gray zone lymphoma.Immune checkpoint inhibitors are drugs produced by pharmaceutical companies that are often made of antibodies. Researchers are...